Thoratec : Thoratec inks $12m investor suit settlement deal

Abbott (NYSE:ABT) owned Thoratec is seeking approval for a $11.9 million deal to settle class action claims that it and some of its officers hid facts about its Heartmate II heart pump's thrombosis rate that would have negatively affected share prices, according to recently released court documents. Investor Bradley Cooper originally brought the suit against the company [...]The post Thoratec inks $12m investor suit settlement deal appeared first on MassDevice.